Dr Emma Hargreaves (nee Mead) completed her first degree in Biochemistry with a year in Industry, graduating in 2003 from the University of Kent. She spent her year in industry at Pfizer working in the orphanG-Protein Coupled Receptor (GPCR) group, followed by a summer studentship within the Drug Metabolism group. Emma went on to complete a PhD studying the emerging pharmacology of orphan GPCRs in the Clinical Pharmacology Group at the University of Cambridge.
In 2007 Emma joined the group of Professor Mark Smales at the University of Kent and she now has more than 10 years experience working in the Translational Control and Industrial Biotechnology area. In 2012 Emma was awarded an independent Leverhulme Trust Early Career Fellowship on ‘Determining control of mRNA translation via changes of translation factor levels’ which she completed in 2016 before returning to work in the group of Professor Smales.
Emma has published and presented nationally and internationally. In addition to her research interests, Emma contributes to teaching within the school and is a Fellow of the Higher Education Academy. Emma is a member of the Biochemical Society and in 2018 became a panel member for Research Area I Genes.
Dr Emma Hargreaves research to date has focused on control of mRNA translation during protein production in mammalian cells. Emma’s current project is part of a multi-site collaboration on ‘Regulation of protein synthesis by elongation control in health and disease’ and her particular focus is to interrogate the codons/sequence motifs that confer elongation control in cooled cells.
Biochemical Society Panel member for Research Area I – Genes